Skip to main content
. 2024 Jan 5;8(6):1384–1391. doi: 10.1182/bloodadvances.2023011514

Table 2.

Adverse events

Adverse events, n (%) Grade 1/2 Grade 3/4
Patients with ≥1 events 16 (88.9) 7 (38.9)
 Neutropenia 3 (16.7) 3 (16.7)
 Thrombocytopenia 2 (11.1) 6 (33.3)
 Anemia 1 (5.6) 0
 Infections and infestations 5 (27.8) 2 (11.1)
 Nausea and vomiting 8 (44.4) 0
 Fatigue and weakness 5 (27.8) 0
 Anorexia 3 (16.7) 0
 Headache 3 (16.7) 0
 Rash 2 (11.1) 0
 Abdominal pain 2 (11.1) 0
 Acute GVHD 2 (11.1) 0
 Diarrhea 2 (11.1) 0
 Elevated bilirubin 1 (5.6) 0
 Fever 1 (5.6) 0